Diabetes Discourse
Investigating SGLT-2 Inhibitors in Diabetes: Considerations & Conversation
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Mas informaciones
Informações:
Sinopsis
Host: John Buse, MD, PhD Guest: Anne Louise Peters, MD SGLT-2 inhibitors have been authorized for diabetic patients in Europe, but is it close to receiving FDA approval in the U.S.? Dr. Anne Peters of USC speaks with Dr. John Buse about SGLT-2 inhibitors and considerations for diabetic ketoacidosis, heart failure, and chronic kidney disease.